FAVORABLE ENVIRONMENTS

March 11, 2026

#17 - Dr. Patrick Hogan: Building Awareness Against the Silent Pandemic of Antimicrobial Resistance

Listen and subscribe on your favorite platform

Apple Podcasts
Spotify

In this episode of Favorable Environments, Tung Nguyen speaks with Dr. Patrick Rynn Hogan, DHA, author of the newly published book The Silent Pandemic of Antimicrobial Resistance: Why the Next Global Health Crisis Has Already Begun and CEO of Prescient Healthcare, about one of the most urgent yet under-recognized threats to modern health. Dr. Hogan explains antimicrobial resistance (AMR) as a system-level failure spanning healthcare infrastructure, agricultural practices, supply chains, and innovation pipelines—where once-treatable infections like UTIs, sepsis, and minor wounds now contribute to hundreds of thousands of deaths annually as microbes evolve beyond standard antibiotics.

The conversation delves into key drivers of AMR: widespread antibiotic use in livestock (accounting for about 60% of global consumption), leading to environmental dissemination through soil, water, and food systems; post-COVID strains on rural hospitals and access gaps in states like South Dakota; and the stagnation in new antibiotic development due to limited profitability and reimbursement challenges. Dr. Hogan highlights South Dakota’s moderate-risk profile—strong statewide reporting to the CDC and proactive health systems balanced against higher prescribing rates and rural geography—and the interconnected ecosystem risks amplified in agriculture-heavy regions.

Drawing on historical pandemics and today’s hyper-connected world, he stresses preparedness through everyday actions (completing full antibiotic courses, rigorous hygiene, proper food handling), better surveillance and transparent reporting (often masked under sepsis or UTI labels), and accelerated innovation in therapeutics, data tools, and AI for analysis and decision support. Dr. Hogan views AMR as a ripe field for disruption, calling for pharma investment, improved communication, and interdisciplinary collaboration to avert a future where resistant infections rival cancer in mortality.

This episode offers a grounded look at why awareness and proactive steps matter now—as populations age and vulnerabilities rise—and how South Dakota’s tight networks, statewide support, and emerging bioscience ecosystem create scalable advantages for addressing rural health challenges, advancing diagnostics and treatments, and building long-term resilience. The discussion underscores the USD Discovery District’s role as a conduit for university research, private sector ambition, and community impact in fostering favorable environments for mission-driven innovation in biotech, medtech, and global health security.

To stay connected with the USD Discovery District, follow us on LinkedIn at linkedin.com/company/usd-discovery-district and discover opportunities at usddiscovery.com, including leasing at Building 1 for research, diagnostics, and advanced manufacturing.

Favorable Environments is presented by the USD Discovery District and supported by South Dakota First Capital, working to expand access to capital for companies building the future of bioscience in the region.

About this Guest

Patrick Hogan, DHA

Dr. Patrick Rynn Hogan, DHA, is a healthcare executive, scholar, and author specializing in public health, health systems resilience, artificial intelligence, and global risk. Holding a Doctor of Health Administration, he has extensive experience across healthcare delivery, population health analytics, employer-sponsored health strategy, and health technology innovation. As CEO and Co-Founder of Prescient Healthcare, he leads an AI-enabled decision intelligence platform that functions as a virtual “Chief Medical Officer” for self-insured employers and public-sector organizations. The platform integrates clinical, claims, and workforce data to detect emerging health risks early, quantify economic impacts, and drive evidence-based interventions that reduce avoidable utilization and improve workforce outcomes, with a strong emphasis on explainable AI, governed analytics, and real-world applicability.
 
Dr. Hogan also serves as Board Chair of Celbridge Science, advancing non-animal methods and in-silico analytics to reduce reliance on animal testing in biomedical research through partnerships with academic institutions and the National Institutes of Health. His career includes leadership roles in healthcare consulting, digital health, and analytics, focusing on clinical workflows, population health management, and enterprise data platforms while addressing systemic vulnerabilities such as workforce shortages and misaligned incentives during crises. He is the author of The Silent Pandemic of Antimicrobial Resistance: Why the Next Global Health Crisis Has Already Begun, which examines antimicrobial resistance as a systemic threat exposing weaknesses in medicine, governance, and global cooperation, advocating integrated solutions across science, policy, and operations for interconnected challenges like pandemic preparedness and chronic disease.

Explore Other Episodes

#8 – Aaron Emerson: Never Walking the Grey

Aaron is the Chief Executive Officer at CEGA Innovations located in Sioux Falls, SD. Before co founding CEGA, Aaron honed his expertise as a litigation attorney, specializing in complex commercial disputes and risk advisement. His rich background also extends into the academic realm, having delved into neuroscience at the University of South Dakota and Creighton University School of Medicine, kidney ischemia research at University Physicians, and cardiovascular studies at the University of Nebraska Medical Center.

Read More »
May 17, 2024

#1 – Tom Ulrich: Leading Engineers and Organizational Culture

Tom Ulrich is a seasoned engineer and engineering manager with over 30 years of experience, a consultant, an Engineering Fellow at Tandem Diabetes, and an Adjunct Professor of Engineering at Biola University. He is also the author of ‘Leading Engineers,’ a book tailored for engineering managers that melds the wisdom accrued from his extensive career in engineering and management with insightful leadership theories from academia.

Read More »
November 17, 2023

#13 – Wassim Laroussi: Exploring Public Biotech Stocks

Wassim Laroussi is the founder and creator of The Biotech Investor Youtube channel.

The Biotech Investor is dedicated to exploring the biotechnology sector, with a focus on small to medium-sized companies developing innovative therapies and medications. The channel provides biweekly financial analyses of promising biotech stocks, offering insights into their potential impact on healthcare. Each episode covers recent developments and key factors for investors to consider. Aimed at both experienced and new investors, The Biotech Investor delivers clear, detailed information to support informed decision-making in the evolving world of biotechnology.

Read More »
August 1, 2025

Join our newsletter for regular updates on the podcast, USD Discovery District, and medtech and life science related insights.

By submitting your email to subscribe, you agree to our Privacy Policy.

Proudly Sponsored By